Volume 15, Number 4—April 2009
Multigenotype Q Fever Outbreak, the Netherlands
Highlight and copy the desired format.
|EID||Klaassen CH, Nabuurs-Franssen MH, Tilburg JJ, Hamans MA, Horrevorts AM. Multigenotype Q Fever Outbreak, the Netherlands. Emerg Infect Dis. 2009;15(4):613-614. https://dx.doi.org/10.3201/eid1504.081612|
|AMA||Klaassen CH, Nabuurs-Franssen MH, Tilburg JJ, et al. Multigenotype Q Fever Outbreak, the Netherlands. Emerging Infectious Diseases. 2009;15(4):613-614. doi:10.3201/eid1504.081612.|
|APA||Klaassen, C. H., Nabuurs-Franssen, M. H., Tilburg, J. J., Hamans, M. A., & Horrevorts, A. M. (2009). Multigenotype Q Fever Outbreak, the Netherlands. Emerging Infectious Diseases, 15(4), 613-614. https://dx.doi.org/10.3201/eid1504.081612.|
To the Editor: Q fever is a zoonosis caused by Coxiella burnetii (1). An ongoing Q fever outbreak has occurred in the Netherlands since 2007; incidence rates have increased >50-fold compared with the baseline rate (2). The source of this outbreak is unknown. Identifying the source of an infection is complicated because of difficulties in obtaining sufficient clinical and/or environmental samples for testing. Molecular diagnosis of Q fever has focused on the use of serum samples. Up-to-date genotyping of C. burnetii has depended on cultivation and enrichment of the isolate before analysis (3). We report multiple-locus variable-number tandem repeat analysis (MLVA) typing of C. burnetii for a variety of human and animal clinical samples obtained from different locations in the Netherlands (Table).
Severe pneumonia developed in patient 1 after close contact with sheep (ewes) and intimate cuddling with a newborn lamb. Patients 2 and 3 (a dairy goat farmer and his wife from another village) tested positive for Q fever after a large part of their goat herd aborted offspring. The farmer had no clinical symptoms; his wife had mild symptoms that disappeared spontaneously within 2 days. No samples from any of the goats were available. Two additional patients were tested, 1 of which lived in the same village as patients 2 and 3.
Swab specimens from all sheep and lambs tested in the first case yielded identical MLVA genotypes. The same genotype was also found in patient 1 but not in the other examined samples, implicating sheep as the origin of patient 1’s infection. Although patients 2 and 3 live together, the genotype found in patient 2 differed from the (partial) genotype found in patient 3. Yet another genotype was found in a patient from the same village (patient 4). However, an identical genotype found in patient 2 was found in a patient from a distant village (patient 5). The village had only 1 goat farm, and if this herd of goats was the source of infection for the farmer, his wife, and patient 4, it would have contained >1 genotype. At least 1 of the obtained genotypes has spread over a wider surface area in the Netherlands.
Our results show that the unprecedented, ongoing Q fever outbreak in the Netherlands involves multiple genotypes of C. burnetii. Because most of the genotypes differ only by a single repeat difference, they might represent microvariants of a hypervirulent strain that has been introduced in the Dutch animal population. MLVA schemes with up to 17 markers have been previously reported (3). In this “proof of concept” (applying direct genotyping of C. burnetti on clinical samples), we focused on the 3 shortest repeat units because we believed that these units might have the highest à priori chance of successful amplification in clinical samples (especially in serum/plasma). Similar genotypes as those reported here were found in the MLVA database (http://mlva.u-psud.fr), but these similarities need confirmation by using more markers. Although using only 3 markers may lead to poor discriminatory power, we were still able to distinguish 4 different genotypes in a relatively small collection of serum samples. We are currently exploring the use of additional MLVA markers.
Our results also show a poor correlation between DNA load and clinical symptoms. Multiple human and animal clinical samples, including serum and plasma, throat or genital swabs, or sputum and urine, may be useful for direct genotyping and outbreak source tracking.
- Raoult D, Marrie TJ, Mege JL. Natural history and pathophysiology of Q fever. Lancet Infect Dis. 2005;5:219–26.
- Schimmer B, Morray G, Dijkstra F, Schneeberger PM, Weers-Pothoff G, Timer A, Large ongoing Q fever outbreak in the south of the Netherlands, 2008. Euro Surveill. 2008;13:pii=18939 [cited 2009 Feb 18]. Available from http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18939
- Arricau-bouvery N, Hauck Y, Bejaoui A, Frangoulidis D, Bodier CC, Souriau A, Molecular characterization of Coxiella burnetii isolates by infrequent restriction site-PCR and MLVA typing. BMC Microbiol. 2006;6:38.
TableCite This Article
Please use the form below to submit correspondence to the authors or contact them at the following address:
Corné H.W. Klaassen, Department of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital, Weg door Jonkerbos 100, 6532 SZ Nijmegen, the Netherlands
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: December 10, 2010
- Page last updated: December 10, 2010
- Page last reviewed: December 10, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)